↓ Skip to main content

Dove Medical Press

Article Metrics

A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, February 2016
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
53 Mendeley
Title
A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD
Published in
International Journal of Chronic Obstructive Pulmonary Disease, February 2016
DOI 10.2147/copd.s91118
Pubmed ID
Authors

Marc Miravitlles, Jéssica Montero-Caballero, Frank Richard, Salud Santos, Juan Luis García-Rivero, Francisco Ortega, Xavier Ribera

Abstract

Delivery of inhaled medications via an inhaler device underpins the effectiveness of treatment for patients with chronic obstructive pulmonary disease (COPD). Correct inhaler technique among patients is also a predictor of achieving treatment compliance and adherence. Reporting of patient satisfaction with inhalers is therefore gaining increasing attention and is now recognized as an important patient-reported outcome in clinical trials involving patients with COPD or asthma. In this cross-sectional study, we use the validated Patient Satisfaction and Preference Questionnaire (PASAPQ) to assess the handling and satisfaction for Respimat(®) Soft Mist™ Inhaler (SMI) compared with the Breezhaler(®) dry powder inhaler (DPI) among patients with COPD in Spain. Patients were already assigned to therapy with either SPIRIVA(®) (tiotropium) Respimat(®) or with Hirobriz(®)/Onbrez(®)/Oslif(®) (indacaterol) Breezhaler(®) for at least 3 but not more than 6 months before completing the PASAPQ at a single visit to the study site. The primary endpoint of the trial was the mean total PASAPQ score. Secondary endpoints were the performance score domain of the PASAPQ, the convenience score domain of the PASAPQ, and the overall satisfaction score of the PASAPQ. For the primary endpoint, the mean PASAPQ total score in the Respimat(®) and Breezhaler(®) groups was 80.7 and 79.9, respectively (difference of 0.8, 95% confidence interval [CI] -2.9 to 4.5; P=0.67). The mean total performance scores were 82.5 and 78.2 (difference of 4.3, 95% CI -0.3 to 8.9; P=0.06), and the mean total convenience scores were 78.6 and 81.9 (difference of -3.3, 95% CI -7.0 to 0.4; P=0.08) for the Respimat(®) and Breezhaler(®) groups, respectively. Patients gave the Respimat(®) SMI and the Breezhaler(®) DPI overall satisfaction PASAPQ scores of 6.0 and 5.9, respectively, which shows that patients were satisfied with these inhalers.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 53 100%

Demographic breakdown

Readers by professional status Count As %
Other 14 26%
Researcher 8 15%
Student > Ph. D. Student 6 11%
Student > Bachelor 4 8%
Student > Master 3 6%
Other 10 19%
Unknown 8 15%
Readers by discipline Count As %
Medicine and Dentistry 22 42%
Pharmacology, Toxicology and Pharmaceutical Science 7 13%
Nursing and Health Professions 6 11%
Agricultural and Biological Sciences 2 4%
Psychology 1 2%
Other 3 6%
Unknown 12 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 February 2016.
All research outputs
#5,524,106
of 7,313,486 outputs
Outputs from International Journal of Chronic Obstructive Pulmonary Disease
#682
of 910 outputs
Outputs of similar age
#198,327
of 282,523 outputs
Outputs of similar age from International Journal of Chronic Obstructive Pulmonary Disease
#56
of 67 outputs
Altmetric has tracked 7,313,486 research outputs across all sources so far. This one is in the 13th percentile – i.e., 13% of other outputs scored the same or lower than it.
So far Altmetric has tracked 910 research outputs from this source. They receive a mean Attention Score of 4.2. This one is in the 6th percentile – i.e., 6% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 282,523 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.